Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. [electronic resource]
Producer: 20091211Description: 1511-9 p. digitalISSN:- 1879-355X
- Antineoplastic Agents, Alkylating -- administration & dosage
- Ataxia Telangiectasia Mutated Proteins
- Caffeine -- pharmacology
- Cell Cycle Proteins -- antagonists & inhibitors
- Cell Line, Tumor -- radiation effects
- Checkpoint Kinase 1
- Checkpoint Kinase 2
- Combined Modality Therapy -- adverse effects
- DNA Repair -- drug effects
- DNA-Binding Proteins -- antagonists & inhibitors
- Dacarbazine -- administration & dosage
- Drug Administration Schedule
- G2 Phase -- drug effects
- Glioblastoma -- enzymology
- Humans
- Morpholines -- pharmacology
- Neoplasm Proteins -- metabolism
- O(6)-Methylguanine-DNA Methyltransferase -- metabolism
- Phosphorylation
- Protein Kinases -- metabolism
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Pyrones -- pharmacology
- Radiation Tolerance -- drug effects
- Temozolomide
- Tumor Stem Cell Assay
- Tumor Suppressor Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.